Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 28, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.0425 per share, payable on December 20, 2005 to shareholders of...
-
Oct 27, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the first quarter of fiscal year 2006 ended Sept. 24, 2005. The acquisition of Agis Industries was completed on March 17,...
-
Oct 25, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Perrigo Israel Pharmaceuticals Ltd. (formerly Agis Industries (1983) Ltd.) subsidiary is challenging the patent submitted to...
-
Oct 20, 2005
SCOLR Pharma, Inc. (AMEX: DDD) and Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that they entered into an agreement whereby Perrigo will manufacture and market certain sustained...
-
Oct 20, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its first quarter fiscal 2006 on Thursday, Oct. 27, 2005 at approximately 8:30 a.m. (ET). The...
-
Oct 7, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced that through a partnership with InvaGen Pharmaceuticals, it has received final approval from the U.S. Food and Drug Administration (FDA) to...
-
Sep 21, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announces the following Webcast: What: Perrigo Analysts' Meeting When: Thursday, September 22, 2005, 9:00 a.m. - Noon (ET) And Friday, September 23,...
-
Sep 12, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Famotidine Tablets USP,...
-
Sep 7, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the full year and fourth quarter ended June 25, 2005. The acquisition of Agis Industries was completed on March 17, 2005....
-
Aug 29, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its fourth quarter and fiscal year 2005 on Wednesday, Sept. 7, 2005 at approximately 8:30 a.m....
-
Aug 25, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that, through a partnership with InvaGen Pharmaceuticals, it has received tentative approval from the U.S. Food and Drug...
-
Aug 5, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable on September 20, 2005 to shareholders of record...
-
Jul 19, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market prescription Ibuprofen...
-
Jun 24, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market over-the- counter (OTC)...
-
Jun 16, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has adopted a written trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934 to facilitate the repurchase of...
-
May 5, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the third quarter and nine months of fiscal 2005 ended March 26, 2005. Perrigo Company (in thousands, except per share...
-
Apr 28, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Naproxen Tablets USP, 250...
-
Apr 28, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its third quarter on Thursday, May 5, 2005 at approximately 8:30 a.m. (ET). The Company will...
-
Apr 26, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors has authorized the repurchase of up to $30 million of the Company's common stock over the next 12 months....
-
Apr 22, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable on June 21, 2005 to shareholders of record on...
-
Apr 11, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Agis Industries subsidiary has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market...
-
Mar 17, 2005Creates global provider of generic prescription drugs, active pharmaceutical ingredients and consumer healthcare products
The Perrigo Company (NASDAQ: PRGO) today announced the completion of its acquisition of Agis Industries (1983) Ltd., a developer and manufacturer of specialized generic pharmaceuticals and active...
-
Mar 15, 2005
The Perrigo Company (NASDAQ: PRGO) announced today that its shareholders approved the issuance of shares of Perrigo common stock in connection with the November 14, 2004 agreement and plan of...
-
Feb 4, 2005
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable on March 22, 2005 to shareholders of record on February 25,...
-
Feb 1, 2005
The Perrigo Company (NASDAQ: PRGO) today announced results for the second quarter and six months of fiscal 2005 ended Dec. 25, 2004. Perrigo Company (in thousands, except per share amounts) Second...